BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28807364)

  • 1. Initial results of the oesophageal and gastric cancer registry from the Comunidad Valenciana.
    Escrig J; Mingol F; Martí R; Puche J; Trullenque R; Barreras JA; Asencio F; Aguiló J; Navarro JM; Alberich C; Salas D; Lacueva FJ;
    Cir Esp; 2017 Oct; 95(8):428-436. PubMed ID: 28807364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
    Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
    Shapiro J; van Lanschot JJB; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch ORC; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Bilgen EJS; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A;
    Lancet Oncol; 2015 Sep; 16(9):1090-1098. PubMed ID: 26254683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland.
    Kauppila JH; Ohtonen P; Karttunen TJ; Kokkola A; Laine S; Rantanen T; Ristimäki A; Räsänen JV; Saarnio J; Sihvo E; Toikkanen V; Tyrväinen T
    BMJ Open; 2019 Jan; 9(1):e024094. PubMed ID: 30782726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of postoperative morbidity and mortality after surgery for gastro-oesophageal carcinomas.
    Liedman BL; Bennegård K; Olbe LC; Lundell LR
    Eur J Surg; 1995 Mar; 161(3):173-80. PubMed ID: 7599295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of staging investigations for oesophago-gastric carcinoma.
    Clements DM; Bowrey DJ; Havard TJ
    Eur J Surg Oncol; 2004 Apr; 30(3):309-12. PubMed ID: 15028314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.
    Trip AK; Stiekema J; Visser O; Dikken JL; Cats A; Boot H; van Sandick JW; Jansen EP; Verheij M
    Acta Oncol; 2015 Nov; 54(10):1754-62. PubMed ID: 25797568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
    Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
    Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in outcomes of oesophageal and gastric cancer surgery across Europe.
    Dikken JL; van Sandick JW; Allum WH; Johansson J; Jensen LS; Putter H; Coupland VH; Wouters MW; Lemmens VE; van de Velde CJ; van der Geest LG; Larsson HJ; Cats A; Verheij M
    Br J Surg; 2013 Jan; 100(1):83-94. PubMed ID: 23180474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008.
    Coupland VH; Lagergren J; Lüchtenborg M; Jack RH; Allum W; Holmberg L; Hanna GB; Pearce N; Møller H
    Gut; 2013 Jul; 62(7):961-6. PubMed ID: 23086798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of survival from carcinoma of oesophagus and oesophago-gastric junction following surgical resection using an artificial neural network.
    Mofidi R; Deans C; Duff MD; de Beaux AC; Paterson Brown S
    Eur J Surg Oncol; 2006 Jun; 32(5):533-9. PubMed ID: 16618533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohort profile: a nationwide population-based retrospective assessment of oesophageal cancer in the Finnish National Esophago-Gastric Cancer Cohort (FINEGO).
    Söderström HK; Räsänen J; Saarnio J; Toikkanen V; Tyrväinen T; Rantanen T; Valtola A; Ohtonen P; Pääaho M; Kokkola A; Kallio R; Karttunen TJ; Pohjanen VM; Ristimäki A; Laine S; Sihvo E; Kauppila JH
    BMJ Open; 2020 Oct; 10(10):e039575. PubMed ID: 33055119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastro-oesophageal malignancy in New Zealand: 1995-97.
    Martin IG
    N Z Med J; 2002 Feb; 115(1148):64-7. PubMed ID: 11913934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary gastric cancer in an oesophageal gastric graft after oesophagectomy.
    Yoon YS; Kim HK; Choi YS; Kim K; Kim J; Shim YM
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1181-4. PubMed ID: 21868245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term postoperative outcomes of gastric adenocarcinoma patients treated with curative intent in low-volume centers.
    Lacueva FJ; Escrig-Sos J; Marti-Obiol R; Zaragoza C; Mingol F; Oviedo M; Peris N; Civera J; Roig A;
    World J Surg Oncol; 2022 Oct; 20(1):344. PubMed ID: 36253780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.
    Markar SR; Mackenzie H; Wiggins T; Askari A; Karthikesalingam A; Faiz O; Griffin SM; Birkmeyer JD; Hanna GB
    Br J Surg; 2018 Jan; 105(1):113-120. PubMed ID: 29155448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.
    Koppert LB; Lemmens VE; Coebergh JW; Steyerberg EW; Wijnhoven BP; Tilanus HW; Janssen-Heijnen ML
    Br J Surg; 2012 Dec; 99(12):1693-700. PubMed ID: 23132417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
    Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
    Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery.
    Dikken JL; Wouters MW; Lemmens VE; Putter H; van der Geest LG; Verheij M; Cats A; van Sandick JW; van de Velde CJ
    Br J Surg; 2012 Jul; 99(7):954-63. PubMed ID: 22569956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.